Novavax Inc (NVAX) financials · rev $1.12B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Novavax Inc (NVAX) rev $1.12B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $1.12B | $682.2M |
| Cost of Revenue | $73.0M | $202.7M |
| Gross Profit | $1.05B | $479.4M |
| Operating Income | $452.8M | -$248.9M |
| Net Income | $440.3M | -$187.5M |
| EPS (Diluted) | $2.58 | -$1.23 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.18B | $1.56B |
| Current Assets | $978.3M | $1.13B |
| Cash & Equivalents | $240.6M | $530.2M |
| Inventory | $11.5M | $8.75M |
| PP&E | $44.8M | $138.4M |
| Total Liabilities | $1.30B | $2.18B |
| Current Liabilities | $459.9M | $1.15B |
| Long-term Debt | $244.2M | N/A |
| Total Debt | $244.2M† | N/A |
| Shareholders' Equity | -$127.8M | -$623.8M |
| Retained Earnings | -$4.57B | -$5.01B |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$244.6M | -$87.3M |
| CapEx | $5.56M | $13.1M |
| Investing Cash Flow | -$78.3M | -$204.0M |
| Financing Cash Flow | $27.7M | $260.6M |
| Net Change in Cash | -$289.2M | -$38.5M |
| Free Cash Flow | -$250.2M | -$100.3M |
FAQ
What is NVAX P/E and revenue?
Novavax Inc (NVAX) rev $1.12B.
What is NVAX revenue?
Novavax Inc last cached revenue is $1.12B (FY2025).
Is NVAX profitable?
Novavax Inc last cached net income is $440.3M (FY2025).
What are NVAX total assets?
Novavax Inc last cached total assets are $1.18B (FY2025).
What is NVAX free cash flow?
Novavax Inc last cached free cash flow is -$250.2M (FY2025).
Not investment advice. Cached statements, not a live tape.